Basic Information
| LncRNA/CircRNA Name | LINC01608 |
| Synonyms | NA |
| Region | GRCh38_8:110937690-111027433 |
| Ensemble | ENSG00000253877 |
| Refseq | NR_125416 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | neuroblastoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | tissues,NB cell lines |
| Expression Pattern | differential expression |
| Function Description | The top 10 ranked lncRNAs based on the MED analysis are LOC440896, LOC729770, LINC00632, CXCR2P1,LOC643542, LOC387720, IGF2-AS, DUX4L3, HAS2-AS1, and LINC01612. |
| Pubmed ID | 30914706 |
| Year | 2019 |
| Title | Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma. |
External Links
| Links for LINC01608 | GenBank HGNC NONCODE |
| Links for neuroblastoma | OMIM COSMIC |